Dermal fillers restore volume, smooth wrinkles, and reshape facial contours using FDA-approved injectable materials placed beneath the skin [6][8]. Houston’s market offers nearly every major FDA-approved filler brand — but with real risks that deserve honest discussion, not marketing language. This guide covers what the evidence supports, what Houston practices actually charge, and how to verify a provider’s credentials under Texas’s updated 2025 medical aesthetics rules.
Every Houston provider listed on Med Spas of Houston has been credential-verified through the Texas Medical Board.
Mechanism
How dermal fillers work
Dermal fillers are FDA-approved injectable materials — most made from hyaluronic acid (HA), a substance naturally present in skin [6]. Four main material categories exist, and the differences matter:
Hyaluronic acid (HA) fillers are the most common. They work immediately, hold water to create volume, and are the only fillers that can be reversed [11]. Duration ranges from 6 months (lips) to 24 months (cheeks with high-density products).
Calcium hydroxylapatite (CaHA), sold as Radiesse, provides immediate volume plus long-term collagen stimulation through direct fibroblast activation — documented to drive up to 160% collagen increase in treated tissue [15][16]. Duration 12–18 months.
Poly-L-lactic acid (PLLA), sold as Sculptra, is a biostimulator rather than a traditional filler. It doesn’t create immediate volume — instead, the PLLA particles are gradually processed by macrophages, which signal fibroblasts to produce collagen [13][14]. Results build over 3–6 months across 2–3 sessions, with effects lasting 2+ years.
Polymethyl methacrylate (PMMA), sold as Bellafill, is semi-permanent. The PMMA microspheres remain in tissue and become encapsulated in the patient’s own collagen [5]. FDA-approved for nasolabial folds (2006) and atrophic acne scars (2015). Not currently offered by any surveyed Houston practice, likely due to required skin testing, semi-permanent nature, and litigation considerations.
Products
FDA-approved filler brands
The common claim that “19 dermal fillers are FDA-approved” is outdated. As of April 2026, approximately 24 marketed FDA-approved dermal filler products exist across 8 brand families, following three significant 2025 approvals [8][9][10].
Major HA filler families
Juvéderm (AbbVie/Allergan): The most widely used family, containing Ultra XC (2010), Ultra Plus XC (2010), Voluma XC for cheeks (2013), Volbella XC for lips and under-eyes (2016; under-eye indication added 2022), Vollure XC (2017), Volux XC for jawline (2022), and SkinVive microdroplet injection for skin quality (2023) [2].
Restylane (Galderma): Original Restylane (2003), Restylane-L with lidocaine, Silk for lips (2014), Lyft for cheeks and hands (2015 cheeks; hand indication added 2018), Refyne and Defyne for smile lines (2016), Defyne for chin (2021), Kysse for lips (2020), Contour for cheeks (2021), and Eyelight for tear troughs (2024) [26].
RHA Collection (Revance/Teoxane): RHA 2, 3, and 4 approved for dynamic wrinkles (2017), Redensity for perioral lines (2020), and RHA Dynamic Volume — newly FDA-approved in June 2025 for midface contour deficiencies [10]. Important Houston note: no surveyed Houston practice currently offers RHA Collection products. Patients seeking RHA may need to travel or wait for broader adoption.
Belotero Balance (Merz): Approved 2011 for nasolabial folds; used off-label for fine lines in delicate areas.
Evolysse (Evolus, partnered with Symatese): Evolysse Form and Smooth — FDA-approved March 2025 [8]. First new HA cross-linking technology from a major US market entrant in nearly a decade.
Obagi saypha MagIQ (Waldencast/Croma-Pharma): FDA-approved September 2025 [9]. Marks Obagi Medical’s entry into the US injectable filler market.
Non-HA fillers
Radiesse (Merz): Calcium hydroxylapatite, FDA-approved 2006 for moderate-to-severe facial folds and hand volume loss [4]. Widely available in Houston but almost never published with per-syringe pricing online, consistent with Merz’s value-positioning approach.
Sculptra (Galderma): Poly-L-lactic acid, FDA-approved 2004 for HIV-associated facial lipoatrophy; cosmetic indication added 2009; body contouring applications common off-label [3].
Bellafill (Suneva/Tiger Aesthetics Medical): PMMA microspheres, FDA-approved 2006 for nasolabial folds; indication expanded 2015 for atrophic acne scars [5].
What to expect
During and after treatment
Most sessions take 15–60 minutes. Topical numbing cream is typically applied 20–30 minutes before injection. Most modern fillers contain lidocaine, which provides progressive numbness as the product is injected. Expect brief pinching sensations — not the sharp pain many first-time patients anticipate.
-
Immediately after
Small raised bumps at injection sites are normal and resolve within 15–30 minutes. Mild redness is typical. Patients can return to most activities the same day.
-
First 24 hours
Avoid lying face-down, strenuous exercise, alcohol, and heat exposure. No massage of the treatment area. Avoid dental work for 2 weeks — retrograde pressure can displace filler.
-
Days 2–7
Initial swelling resolves. Some patients experience bruising — more common with needles than cannulas, and more common in thin-skinned areas like lips and tear troughs. Arnica and bromelain may reduce bruise duration (evidence mixed but risk low).
-
2-week follow-up
Final assessment of results. Most practices offer a touch-up if small adjustments are needed; some charge for additional product. Lip filler integrates over this window, softening any initial lumpiness.
-
6–24 months
Duration varies by product and area. Lip filler breaks down fastest (6 months) because of constant movement and blood supply. Cheek and jawline filler can last 18–24 months. Biostimulators (Sculptra, Radiesse) build progressively over 3–6 months and last 12–24 months.
Scheduling for events. Most Houston patients schedule filler treatments 2–3 weeks before significant events so swelling and bruising fully resolve. For weddings and major photographed events, 3–4 weeks is safer.
Safety
Vascular occlusion and blindness
This is the most important safety section on this page. Read it.
The most serious dermal filler complication is vascular occlusion — filler inadvertently injected into or compressing an artery, cutting off blood supply to surrounding tissue. If the affected vessel connects to the ocular circulation, the result can be permanent blindness.
The numbers
- Estimated incidence of vascular occlusion: ~1 : 6,558 injections [18][19]
- Cumulative documented cases of filler-induced blindness: 511 worldwide (most recent Beleznay et al. review, 2024/2025) [22]
- New blindness cases 2018–2023 alone: 365 — a dramatic acceleration [22]
- Vision recovery rate: 32% achieve any meaningful recovery; 68% experience no recovery [22]
- Only prognostic factor for better outcome: partially preserved visual acuity at onset [22]
The blindness case surge reflects the explosive growth of cosmetic filler volume globally — millions of procedures performed annually, with injection into facial arteries that anastomose with the ophthalmic artery causing retrograde embolization to the retina.
High-risk zones
The areas with highest risk of vascular occlusion are glabella, nasolabial folds, nose, forehead, and temples [18]. These contain vessels connecting to the retinal and ocular circulation. This doesn’t mean injections in these areas are unsafe — skilled injectors manage them daily — but it does mean provider selection for these areas matters significantly more than for lip augmentation or cheek volumization.
Reversal: hyaluronidase and time
For HA fillers, the emergency treatment is hyaluronidase — an enzyme that rapidly dissolves hyaluronic acid [11][23]. Time-to-treatment is the most important factor; the goal is hyaluronidase administration within 60–90 minutes of symptom onset. Every practice that injects HA fillers should stock hyaluronidase on-site.
One important clinical nuance: HA filler dissolution resistance varies up to 6-fold across cross-linking technologies. Vycross-technology fillers (including Juvéderm Volux) require approximately 120 units of hyaluronidase per 0.2 mL of filler, compared to NASHA fillers (Restylane) which dissolve with substantially less [11][12]. Emergency protocols should account for this.
Non-HA fillers (Radiesse, Sculptra, Bellafill) cannot be reversed by hyaluronidase. This is one reason HA fillers are the default for most patients — the safety net exists.
The incidence numbers above aren’t meant to frighten patients away from fillers. Millions of procedures occur safely every year. But these risks are why Texas classifies filler injection as the practice of medicine, why FDA-cleared products require physician delegation, and why a “deal” on fillers from an unsupervised injector is not a deal.
Emerging safety
The bone resorption question
A newer and underdiscussed safety concern: a 2024 imaging study found bone resorption in 35.9% of chin filler patients who received supraperiosteal HA injection [24]. HA fillers were previously assumed inert at the bone interface. The study suggests that direct-on-bone placement of HA may cause measurable bone loss over time.
Clinical implications are still being established. The finding does not mean filler should be avoided, but it may influence future injection planning — some injectors have already shifted toward subperiosteal or deep dermal placement rather than direct supraperiosteal injection in certain areas.
Safety
Side effects and safety
Most side effects are mild and temporary. Published rates from peer-reviewed literature:
| Side Effect | Rate | Note |
|---|---|---|
| Bruising at injection site | 20–30% | Most common; resolves 7–14 days [28] |
| Swelling | Common | Typically 3–7 days; Vycross products more edematous [29] |
| Palpable nodules | 1.5–5% | Massage or hyaluronidase resolves most [28] |
| Tyndall effect (bluish discoloration) | 1–5% in thin-skin areas | Preventable with deeper placement [30] |
| Granulomas | <1% | Delayed (weeks to months); typically biofilm-associated |
| Delayed-onset inflammatory reactions | Increased since COVID-19 | Case reports following infection or vaccination [31] |
| Vascular occlusion | ~1:6,558 | Medical emergency — see above [18] |
Pregnancy and breastfeeding. No dermal filler is recommended during pregnancy or breastfeeding. This recommendation is based on the precautionary principle rather than evidence of harm — ethical constraints prevent research on pregnant populations [32]. HA itself is naturally occurring, but injection trauma, lidocaine exposure, and potential complications make elective cosmetic treatment inappropriate during pregnancy.
Other contraindications: active infection at injection site, known hypersensitivity to filler material or lidocaine, autoimmune disorders (relative contraindication depending on severity), bleeding disorders, and current anticoagulant use (relative — increases bruising).
Clinical concept
The “liquid facelift” — what it actually is
A “liquid facelift” combines neurotoxin (Botox, Dysport, or another brand) with multiple strategically placed fillers to address both dynamic wrinkles and volume loss in one coordinated treatment plan [27]. It’s a legitimate clinical approach that can produce meaningful improvement for patients with mild-to-moderate facial aging.
What it isn’t: a surgical facelift equivalent. No peer-reviewed study has demonstrated that liquid facelifts match surgical facelifts in lift magnitude, longevity, or structural change. Surgical facelifts reposition the SMAS layer, remove excess skin, and produce results lasting 7–15 years. Liquid facelifts address volume and surface — they do not produce the same structural change.
For patients with significant laxity, skin excess, or who want one-time long-lasting correction, surgery remains the standard of care. For patients with mild-to-moderate aging who want subtle, adjustable improvement with minimal downtime, a well-executed liquid facelift can deliver excellent results.
In Houston
Houston climate considerations
Houston’s heat, humidity, and year-round UV exposure create specific post-treatment considerations:
Heat exposure. Avoid saunas, hot yoga, hot tubs, and outdoor exercise in direct sun for 48–72 hours post-injection. Heat-induced vasodilation can increase swelling and theoretically affect filler settling.
Sun exposure. Houston’s intense UV can darken any post-injection bruising. Sunscreen on treatment areas for 7–14 days reduces post-inflammatory hyperpigmentation risk, particularly important for Houston’s diverse Fitzpatrick skin type population.
Humidity and sweating. Houston summer humidity means heavy sweating resumes quickly outside air-conditioned spaces. Pat injection sites dry; avoid heavy outdoor activity for at least 4–6 hours post-treatment.
Pricing
Houston pricing
Houston’s competitive filler market keeps per-syringe pricing at or slightly below national averages. ASPS reports a national average of $715 per syringe for HA filler [1]. Houston tracks similarly.
| Tier | Per-Syringe (HA) | Provider Type |
|---|---|---|
| High-volume / nurse-injector | $499–$649 | RN-owned or NP-led med spas with transparent pricing |
| Mid-range med spa | $650–$799 | Established med spas with physician oversight |
| Premium / surgeon-led | $800–$950 | Board-certified plastic or facial plastic surgeons |
Per-area pricing examples
Typical Houston total costs for common treatment plans, before loyalty-program discounts:
| Treatment | Typical Syringes | Houston Price Range |
|---|---|---|
| Lip augmentation (subtle) | 0.5–1 | $300–$800 |
| Lip augmentation (fuller) | 1 | $500–$900 |
| Nasolabial folds | 1–2 | $650–$1,600 |
| Full cheek augmentation | 2–4 | $1,300–$3,000 |
| Under-eye hollows (both sides) | 1 | $599–$900 |
| Jawline contouring | 2–4 | $1,400–$3,200 |
| Full-face “liquid facelift” | 4–8 syringes + Botox | $3,000–$8,000 |
| Sculptra full face (series) | 2–4 vials across sessions | $1,500–$3,200 |
Transparency split
Houston’s market divides cleanly. Transparent pricing: BotoxRN, DermaTouch RN, Dream Aesthetics, OVME, Galleria Aesthetics, myEvergreen all publish per-syringe pricing online [42]. Consultation-only: Memorial Plastic Surgery, Boynton Plastic Surgery, Dr. Mentz/ACPS, and most board-certified plastic surgeon practices require in-person consultation before quoting. Expect 15–25% premiums at this tier.
What you won’t find in Houston
RHA Collection (RHA 2, 3, 4, Redensity, Dynamic Volume) is not currently offered by any surveyed Houston practice despite being FDA-approved since 2017. Bellafill is similarly absent — likely due to required skin testing and semi-permanent nature. Radiesse is widely available but almost never published with per-syringe pricing online.
Loyalty programs that save money
| Program | Brand Coverage | How It Works |
|---|---|---|
| Allē (AbbVie) | Juvéderm family, Botox, SkinMedica | Product-for-points model (revamped October 2024) [40] |
| Aspire (Galderma) | Restylane family, Dysport, Sculptra, Alastin | Points-per-dollar; stacks with practice promos [41] |
| Xperience+ (Merz) | Radiesse, Belotero, Xeomin | Tiered rewards [37][38] |
Note on Revance. Unlike AbbVie, Galderma, and Merz, Revance does not offer a consumer loyalty program covering RHA fillers or Daxxify. A Daxxify patient rebate program exists but isn’t a true points-based loyalty system [39]. This represents a meaningful competitive gap in the injectables market.
Practice-level memberships (typically $50–$150/month) often add 10–15% off per-syringe pricing plus complimentary services. Can stack with manufacturer programs.
Choosing a provider
How to choose a dermal filler provider
Provider selection matters more for fillers than for most cosmetic treatments. Filler complications range from minor (bruising, nodules) to catastrophic (blindness, skin necrosis). Skilled injectors with proper emergency protocols prevent most serious outcomes. Unqualified injectors don’t.
Under Texas Medical Board 22 TAC Chapter 169 (effective January 9, 2025), dermal filler injection is the practice of medicine and requires physician involvement [33].
| Provider Type | Can Inject? | Supervision Required |
|---|---|---|
| Physician (MD/DO) | Yes | None — independent authority |
| Physician Assistant (PA) | Yes | Written Prescriptive Authority Agreement [43] |
| Nurse Practitioner / APRN | Yes | Written Prescriptive Authority Agreement (TX is restricted-practice) [43] |
| Registered Nurse (RN) | Yes, under physician delegation | Written protocols + Good Faith Exam by MD, DO, PA, or APRN before injection [33] |
| Esthetician | No | Limited to epidermis only (TDLR) [34] |
The Good Faith Exam is critical: a licensed medical provider (MD, DO, PA, or APRN) must conduct an in-person or telehealth evaluation, review medical history, and authorize the treatment before any cosmetic injection. RNs and other staff cannot perform this evaluation. A practice that skips this step is operating outside Texas regulations.
Emergency preparedness
Beyond credentials, verify the practice stocks hyaluronidase on-site for emergency HA filler reversal. Time-to-treatment matters — ideally within 60–90 minutes of vascular symptoms. A practice that doesn’t stock hyaluronidase should not be injecting HA fillers.
2025 Texas legislative updates
- HB 3749 (“Jenifer’s Law”) was signed June 20, 2025 (effective September 1, 2025). Originally proposed broad med spa oversight; the final version was narrowed to elective IV therapy only. Dermal filler regulation remains governed by TMB Chapter 169 [35].
- SB 378 (“Botox Party Bill”) would have added explicit penalties for esthetician injection practices. Governor Abbott vetoed it on June 22, 2025 [36]. Esthetician injection was already illegal under existing scope-of-practice rules; the veto leaves enforcement to existing mechanisms.
Verifying credentials — three steps
- Verify the Texas Medical Board license at tmb.state.tx.us. Confirm active status and check for disciplinary actions.
- Verify board certification at certificationmatters.org. For facial aesthetics, the ABMS-recognized boards are ABD, ABPS, and ABFPRS. There is no ABMS-recognized “aesthetic medicine” or “cosmetic surgery” board.
- Verify nurse credentials at bon.texas.gov for RN, NP, or APRN licensure.
Questions to ask at consultation
- What specific filler product do you recommend for my treatment, and why that one versus alternatives?
- Who is the supervising physician, and what is their board certification?
- Did I receive a Good Faith Exam from a qualifying provider before treatment?
- Do you stock hyaluronidase on-site for emergency reversal?
- What is your protocol if I experience vascular occlusion symptoms (pain, blanching, color change)?
- How many of this specific procedure have you personally performed?
- Can I see before-and-after photos of your own work (not stock images)?
Red flags
- No identifiable medical director or supervising physician
- Pricing dramatically below market ($200–$300/syringe when Houston averages $499–$950)
- High-pressure sales tactics or “today only” pricing
- No hyaluronidase on-site
- Treatment without prior medical history review
- Estheticians performing or “assisting” with injections
- No posted physician name and license number in the treatment room (Texas requires this) [33]